ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Outcome"

  • 2016 American Transplant Congress

    Impact of Preformed Anti-HLA Antibodies in the Outcomes of Kidney Transplantation.

    S. Santos,1 J. Malheiro,1 M. Costa,2 A. Campos,1 S. Pedroso,1 M. Almeida,1 L. Martins,1 L. Dias,1 C. Henriques,1 A. Cabrita.1

    1Nephrology, Hospital Santo António, CHP, Porto, Portugal; 2Nephrology, Centro Hospitalar Tondela-Viseu, Viseu, Portugal.

    Background:Anti-HLA antibodies are risk factors for acute and chronic rejection and allograft loss. Its detection represents a major advance and is widely used in organ…
  • 2016 American Transplant Congress

    How Tacrolimus Variability Affects Donor Specific Antibodies, Rejection and Outcome After Kidney Transplantation.

    S. Papachristos, A. John Velvet, A. Summers, A. Tavakoli, R. Dhanda, R. Pararajasingam, B. Forgacs.

    Manchester Transplantation Unit, Manchester Royal Infirmary Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom.

    Purpose:To investigate the effect of tacrolimus(tac) variability on the development of Donor Specific Antibodies(DSA),rejection and outcome in relation to Age, Gender, Ethnicity and Body Mass…
  • 2016 American Transplant Congress

    Liver Transplantation in Patients Actively Drinking Less Than 6 Months Before Transplant Presenting with Acute Decompensation: A Single-Center Experience.

    H. Monsour, D. Victor, M. Boktour, J. Galati, J. Ontiveros, L. Theriot, R. McFadden, C. Mobley, A. Saharia, S. Gordon-Burroughs, A. Gaber, R. Ghobrial.

    Sherrie and Alan Conover Center for Liver Disease and Transplantation, Houston Methodist Hospital, Houston, TX.

    Background: Alcohol is amongst the leading causes of liver disease worldwide. Most centers have a 6-month abstinence requirement before transplantation candidacy. Mortality rates for acute…
  • 2016 American Transplant Congress

    LACE Index Risk Assessment Tool Predicts Liver Transplant Readmissions.

    A. Masoumi,1 R. Barth,2 J. LaMattina,2 D. Bruno,2 L. Hebert,1 N. Schluterman,3 S. Hanish.2

    1University of Maryland Medical Center, Baltimore, MD; 2Department of Surgery, University of Maryland School of Medicine, Baltimore, MD; 3Department of Epidemiology, University of Maryland School of Public Health, Baltimore, MD.

    Background:One-fifth of Medicare patients are readmitted to the hospital an annual cost of $17.4 billion. The LACE Index (Length of stay, Acuity of the admission,…
  • 2016 American Transplant Congress

    Outcomes of Anticoagulation Use for Portal Vein Thrombosis in University of Wisconsin Liver Transplant Patients.

    M. Falls,1 A. Said,2 L. Fernandez,2 D. Foley,2 K. Frith,1 D. Hager,2 H. Hoy,1 G. Leverson,2 J. Mezrich,2 T. Prickette,2 M. Wakefield,2 A. D'Alessandro.2

    1School of Nursing, University of Alabama, Huntsville, AL; 2Transplant Surgery, University of Wisconsin, Madison, WI.

    Background: The prevalence of Portal Vein Thrombosis (PVT) in cirrhotic liver transplant patients increases the risk of morbidity and mortality post-liver transplantation. Current research suggests…
  • 2016 American Transplant Congress

    The Preventive and Therapeutic Effect of Immunoglobulin on Infectious Complications in Donation After Cardiac Death Liver Transplant Recipients: A Prospective Randomized Controlled Study.

    A. Yang, Z. Guo, W. Ju, Y. Chen, M. Han, X. Wang, D. Wang, Y. Ma, A. Hu, X. Zhu, X. He.

    Organ Transplantation Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.

    Aims: To prospectively investigate the preventive and therapeutic effect of immunoglobulin on infectious complications in DCD liver transplant recipients, and synthetically evaluate its influence on…
  • 2016 American Transplant Congress

    Long Term Outcome of De-Novo Autoimmune Hepatitis in Pediatric Recipients of Liver Transplantation.

    Y. Avitzur,1 P. McKiernan,2 M. Martinez,3 S. Lobritto,3 D. Kelly,2 V. Ng,1 E. Alonso,4 U. Ekong.5

    1Hospital for Sick Children, Toronto, Canada; 2Birmingham Children's Hospital, Birmingham, United Kingdom; 3Morgan Stanley Children's Hospital, New York; 4Lurie Children's Hospital, Chicago; 5Yale New Haven Children's Hospital, New Haven.

    Background: De-novo autoimmune hepatitis (DAIH) is a chronic immune mediated graft disorder seen following liver transplantation (LT). The long-term course and outcome of DAIH is…
  • 2016 American Transplant Congress

    Outcomes Following Inguinal Hernia Repair in Kidney Transplant Recipients.

    S. DiBrito, I. Olorundare, C. Landazabal, D. Segev, N. Dagher.

    Transplant Surgery, Johns Hopkins Hospital, Baltimore.

    It is assumed that kidney transplant (KT) recipients have more complications, longer length of stay (LOS) and higher hospital cost associated with general surgery procedures,…
  • 2016 American Transplant Congress

    When Living Donor Liver Allografts Fail: Exploring the Pitfalls of Retransplantation Using Deceased Donor Organs.

    T. Bittermann,1 A. Shaked,2 K. Lloyd,2 D. Goldberg.1

    1Gastroenterology and Hepatology, University of Pennsylvania, Philadelphia, PA; 2Transplant Surgery, University of Pennsylvania, Philadelphia, PA.

    Background: In the US, living donor liver transplantation (LDLT) is associated with increased long-term graft and patient survival compared to deceased donor liver transplantation (DDLT).…
  • 2016 American Transplant Congress

    Long-Term Death-Censored Graft Loss in the DeKAF Study.

    A. Matas,1 A. Fieberg,1 R. Leduc,1 F. Cosio,2 R. Gaston,3 R. Mannon,3 M. Cecka,4 D. Rush,7 B. Kasiske,5 S. Gourishankar,6 J. Connett,1 J. Grande.2

    1U of MN, Mpls, MN; 2Mayo, Rochester, MN; 3UAB, Birmingham, AB; 4UCLA, LA, CA; 5HCMC, Mpls, MN; 6U Alberta, Edmonton, AB, Canada; 7UMB, Winnipeg, MB, Canada.

    The aim of the Deterioration of Kidney Allograft Function study (DeKAF) was to identify and assess the pathologies of troubled kidney grafts, that is, those…
  • « Previous Page
  • 1
  • …
  • 131
  • 132
  • 133
  • 134
  • 135
  • …
  • 155
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences